High NHLRC2 expression is associated with shortened survival in lung adenocarcinoma

This work was supported by the Foundation of the Finnish Anti-Tuberculosis Association (to MAK, and to RLK), the Tampere Tuberculosis foundation (to MAK), Väinö and Laina Kivi Foundation (to MAK), the Research Foundation of the Pulmonary Diseases (to MAK, and to RLK), Orion research foundation (to MAK), Medical Research Center Oulu (to STL), Academy of Finland profiling program (Decision No. 311934, to RMLH), University of Oulu (to RMLH), the Foundation for Pediatric Research, Finland (to RMLH), the Jalmari and Rauha Ahokas Foundation (to RLK), the Research Foundation of the North Finland (to RLK), and the state subsidy of Oulu University Hospital (to RLK).